Indicators

Markets:

News

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9

...

Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss

August 31, 2023

Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance

August 29, 2023

Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M

August 29, 2023

Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment

August 28, 2023

Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More

August 28, 2023

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

August 28, 2023

Cracking The Code Of Healing: Can Trained Coders Observe Therapeutic Moments In Psilocybin Therapy?

August 25, 2023

Funding The Future Of Psychedelics: Cybin Launches Renewed ATM Equity Program Up To $35M

August 24, 2023

GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026

August 24, 2023

Canada Vs. US: Surveys Reveal How People Use Psychedelics, Relationships With Healthcare Providers

August 23, 2023

Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time

August 23, 2023

Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports

August 21, 2023

Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library

August 16, 2023

$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023

August 16, 2023

Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing

August 15, 2023

Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs

August 15, 2023

Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic

August 14, 2023

Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024

August 14, 2023

MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year

August 14, 2023

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More

August 14, 2023

Multifaceted Artist Kid Cudi Opens Up About Psychedelics, Rehab, Fashion Brand Launch & Being An OG

August 13, 2023

Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA

August 10, 2023

SXSW 2024's Voting Period For 100+ Marijuana & Psychedelics Panels Is On & Upcoming Events Around The Globe

August 09, 2023

Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration

August 09, 2023

Breaking Ground In Prevention & Relief Of Anxiety & PTSD: Silo Pharma' Nasal Formulation For Ketamine-Based Treatment

August 08, 2023

Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound

August 08, 2023

First Ever Professional Practice Guidelines For Providing Psychedelic-Assisted Therapy Published

August 08, 2023

Cybin Closes Short-Lasting Overnight Public Offering With Top Issuance For $8.25M

August 04, 2023

Another Spending Bill Makes Its Way Through Senate, Could Amplify Marijuana & Psychedelics Research

August 03, 2023

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More

August 03, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.